Synergistic effects of sorafenib and cilostazol in HepG2 cells.

Effat H, Mohamed O, Sharaky M, Heikal S, Elshahawy S, Gayad E

DOI: 10.1007/s12038-026-00607-w
Published: 2026
Container: Journal of biosciences
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s12038-026-00607-w,
  title = {Synergistic effects of sorafenib and cilostazol in HepG2 cells.},
  author = {Effat H and Mohamed O and Sharaky M and Heikal S and Elshahawy S and Gayad E},
  year = {2026},
  journal = {Journal of biosciences},
  doi = {10.1007/s12038-026-00607-w},
  url = {https://doi.org/10.1007/s12038-026-00607-w}
}

RIS

TY  - JOUR
TI  - Synergistic effects of sorafenib and cilostazol in HepG2 cells.
AU  - Effat H
AU  - Mohamed O
AU  - Sharaky M
AU  - Heikal S
AU  - Elshahawy S
AU  - Gayad E
PY  - 2026
JO  - Journal of biosciences
DO  - 10.1007/s12038-026-00607-w
UR  - https://doi.org/10.1007/s12038-026-00607-w
ER  -

APA

H, E., O, M., M, S., S, H., S, E., & E, G. (2026). Synergistic effects of sorafenib and cilostazol in HepG2 cells.. Journal of biosciences. https://doi.org/10.1007/s12038-026-00607-w

Source records

pubmed · retrieved 2026-09-26T17:12:27.873Z